Polomar Health signs exclusive distribution deal for inhalable sildenafil and sumatriptan

Polomar Health Services, Inc.

Agreement with ForHumanity Health and Island 40 Group grants exclusivity through Sep 30, 2025, in exchange for $750,000 guaranteed revenue.
ForHumanity made a $250,000 advance payment to secure exclusivity; remaining $500,000 due by June 30, 2025.
Initial term of 3 years through March 2028; auto-renewal for up to 5-year terms if revenue targets met (minimum $3M average annually for first renewal).
Exclusivity can be extended through Dec 31, 2028, if ForHumanity achieves escalating revenue milestones (e.g., $20M by 2027).
Polomar Specialty Pharmacy will fulfill prescriptions; IG4 handles account management.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.